• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康和阿尔茨海默病状态的可计算因果模型及其机制差异分析。

Computable cause-and-effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis.

机构信息

Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, Germany; Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn-Aachen International Center for IT, Bonn, Germany.

Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, Germany.

出版信息

Alzheimers Dement. 2015 Nov;11(11):1329-39. doi: 10.1016/j.jalz.2015.02.006. Epub 2015 Apr 4.

DOI:10.1016/j.jalz.2015.02.006
PMID:25849034
Abstract

INTRODUCTION

The discovery and development of new treatments for Alzheimer's disease (AD) requires a profound mechanistic understanding of the disease. Here, we propose a model-driven approach supporting the systematic identification of putative disease mechanisms.

METHODS

We have created a model for AD and a corresponding model for the normal physiology of neurons using biological expression language to systematically model causal and correlative relationships between biomolecules, pathways, and clinical readouts. Through model-model comparison we identify "chains of causal relationships" that lead to new insights into putative disease mechanisms.

RESULTS

Using differential analysis of our models we identified a new mechanism explaining the effect of amyloid-beta on apoptosis via both the neurotrophic tyrosine kinase receptor, type 2 and nerve growth factor receptor branches of the neurotrophin signaling pathway. We also provide the example of a model-guided interpretation of genetic variation data for a comorbidity analysis between AD and type 2 diabetes mellitus.

DISCUSSION

The two computable, literature-based models introduced here provide a powerful framework for the generation and validation of rational, testable hypotheses across disease areas.

摘要

简介

阿尔茨海默病(AD)新疗法的发现和开发需要深入了解疾病的机制。在这里,我们提出了一种模型驱动的方法,支持系统地识别潜在的疾病机制。

方法

我们使用生物表达语言为 AD 建立了一个模型和一个相应的神经元正常生理学模型,以系统地模拟生物分子、途径和临床结果之间的因果和相关关系。通过模型-模型比较,我们确定了导致潜在疾病机制新见解的“因果关系链”。

结果

通过对我们模型的差异分析,我们确定了一个新的机制,通过神经营养酪氨酸激酶受体 2 型和神经生长因子受体分支的神经营养因子信号通路,解释了淀粉样蛋白-β对细胞凋亡的影响。我们还提供了一个模型指导的遗传变异数据分析示例,用于 AD 和 2 型糖尿病之间的合并症分析。

讨论

这里介绍的两个可计算的、基于文献的模型为跨疾病领域生成和验证合理的、可测试的假设提供了一个强大的框架。

相似文献

1
Computable cause-and-effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis.健康和阿尔茨海默病状态的可计算因果模型及其机制差异分析。
Alzheimers Dement. 2015 Nov;11(11):1329-39. doi: 10.1016/j.jalz.2015.02.006. Epub 2015 Apr 4.
2
Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.基于共享途径的阿尔茨海默病与2型糖尿病(T2DM)的共病分析及T2DM药物的作用
J Alzheimers Dis. 2017;60(2):721-731. doi: 10.3233/JAD-170440.
3
Seizures in Alzheimer's disease.阿尔茨海默病中的癫痫发作
Neuroscience. 2015 Feb 12;286:251-63. doi: 10.1016/j.neuroscience.2014.11.051. Epub 2014 Dec 4.
4
A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.一种能抵抗阿尔茨海默病的突变使淀粉样β前体蛋白无法介导神经毒性。
J Neurochem. 2014 Jul;130(2):291-300. doi: 10.1111/jnc.12717. Epub 2014 Apr 10.
5
Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.基质金属蛋白酶-9过表达在阿尔茨海默病5xFAD小鼠大脑中的神经保护作用。
Neurobiol Dis. 2014 Oct;70:179-89. doi: 10.1016/j.nbd.2014.06.021. Epub 2014 Jul 6.
6
Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.新型阿尔茨海默病APP T714I小鼠模型中的神经元内β淀粉样蛋白与脑容量减少
Neurobiol Aging. 2008 Feb;29(2):241-52. doi: 10.1016/j.neurobiolaging.2006.10.016. Epub 2006 Nov 16.
7
Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing.基于通路的全基因组siRNA筛选分析揭示了APP加工的调控格局。
PLoS One. 2015 Feb 27;10(2):e0115369. doi: 10.1371/journal.pone.0115369. eCollection 2015.
8
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
9
In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.表达脑源性神经营养因子的间充质干细胞对APP/PS1小鼠原代培养神经元神经退行性变影响的体外验证
Neuroscience. 2015 Oct 29;307:37-50. doi: 10.1016/j.neuroscience.2015.08.011. Epub 2015 Aug 20.
10
Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.阿尔茨海默病中的钙与神经元损伤。β-淀粉样前体蛋白代谢异常、自由基及代谢障碍的作用。
Ann N Y Acad Sci. 1994 Dec 15;747:50-76.

引用本文的文献

1
KGG: a fully automated workflow for creating disease-specific knowledge graphs.KGG:一种用于创建疾病特定知识图谱的全自动工作流程。
Bioinformatics. 2025 Jul 1;41(7). doi: 10.1093/bioinformatics/btaf383.
2
Enriched knowledge representation in biological fields: a case study of literature-based discovery in Alzheimer's disease.生物领域中丰富的知识表示:以阿尔茨海默病基于文献的发现为例
J Biomed Semantics. 2025 Mar 20;16(1):3. doi: 10.1186/s13326-025-00328-3.
3
Harnessing the potential of machine learning and artificial intelligence for dementia research.
利用机器学习和人工智能在痴呆症研究中的潜力。
Brain Inform. 2023 Feb 24;10(1):6. doi: 10.1186/s40708-022-00183-3.
4
AI reveals insights into link between CD33 and cognitive impairment in Alzheimer's Disease.人工智能揭示 CD33 与阿尔茨海默病认知障碍之间关联的新见解。
PLoS Comput Biol. 2023 Feb 13;19(2):e1009894. doi: 10.1371/journal.pcbi.1009894. eCollection 2023 Feb.
5
A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism.一种混合方法揭示了针对阿尔茨海默病病理生理机制的药物重新利用候选药物。
Patterns (N Y). 2022 Jan 26;3(3):100433. doi: 10.1016/j.patter.2021.100433. eCollection 2022 Mar 11.
6
Virtual Connectomic Datasets in Alzheimer's Disease and Aging Using Whole-Brain Network Dynamics Modelling.使用全脑网络动力学建模技术研究阿尔茨海默病和衰老中的虚拟连接组学数据集。
eNeuro. 2021 Jul 6;8(4). doi: 10.1523/ENEURO.0475-20.2021. Print 2021 Jul-Aug.
7
A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization.一种从多模态知识协调中合理选择药物再利用候选物的方法。
Sci Rep. 2021 May 26;11(1):11049. doi: 10.1038/s41598-021-90296-2.
8
Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.将 COVID-19 与血液驱动的病理生理学联系起来:一种综合计算实验方法。
Biomolecules. 2021 Apr 27;11(5):644. doi: 10.3390/biom11050644.
9
Clustering of Alzheimer's and Parkinson's disease based on genetic burden of shared molecular mechanisms.基于共享分子机制的遗传负担对阿尔茨海默病和帕金森病进行聚类分析。
Sci Rep. 2020 Nov 5;10(1):19097. doi: 10.1038/s41598-020-76200-4.
10
Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimer's Disease.基于数据的 2 型糖尿病与阿尔茨海默病共病理解中知识组合建模。
J Alzheimers Dis. 2020;78(1):87-95. doi: 10.3233/JAD-200752.